EAM
EFG Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.82M | Buy |
105,024
+65,661
| +167% | +$1.14M | 0.26% | 146 |
|
|
2025
Q1 | $861K | Sell |
39,363
-3,794
| -9% | -$83K | 0.14% | 175 |
|
|
2024
Q4 | $1.38M | Buy |
43,157
+10,087
| +31% | +$322K | 0.19% | 171 |
|
|
2024
Q3 | $953K | Buy |
+33,070
| New | +$953K | 0.16% | 185 |
|
|
2023
Q2 | – | Sell |
-24,031
| Closed | -$1.58M | – | 193 |
|
|
2023
Q1 | $1.58M | Sell |
24,031
-1,346
| -5% | -$88.7K | 0.35% | 99 |
|
|
2022
Q4 | $1.31M | Sell |
25,377
-1,955
| -7% | -$101K | 0.29% | 120 |
|
|
2022
Q3 | $1.87M | Sell |
27,332
-16,320
| -37% | -$1.11M | 0.43% | 79 |
|
|
2022
Q2 | $1.97M | Sell |
43,652
-12,898
| -23% | -$583K | 0.42% | 76 |
|
|
2022
Q1 | $2.87M | Sell |
56,550
-505
| -0.9% | -$25.6K | 0.43% | 67 |
|
|
2021
Q4 | $2.7M | Buy |
+57,055
| New | +$2.7M | 0.35% | 83 |
|